Literature DB >> 2531464

Activation-driven programmed cell death and T cell receptor zeta eta expression.

M Merćep1, A M Weissman, S J Frank, R D Klausner, J D Ashwell.   

Abstract

Activation of spontaneously dividing T cell hybridomas induces interleukin-2 (IL-2) production, a cell cycle block, and programmed cell death. T cell hybridomas that express the T cell antigen receptor (TCR) zeta homodimer (zeta 2), but not the TCR zeta eta heterodimer, were studied. The zeta eta- cells produced little or no inositol phosphates (IP) when stimulated with antigen. In most cases the hydrolysis of phosphoinositides was also impaired after stimulation with antibody to CD3, although one zeta eta- cell produced normal concentrations of IP. The zeta eta- cells slowed their growth and secreted IL-2 in response to both stimuli. However, the zeta eta- cells did not die after activation with antigen. Since activated thymocytes also undergo programmed cell death, these results may have important implications for the role of the zeta eta.TCR in negative selection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531464     DOI: 10.1126/science.2531464

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

1.  Expression of v-src in a murine T-cell hybridoma results in constitutive T-cell receptor phosphorylation and interleukin 2 production.

Authors:  J J O'Shea; J D Ashwell; T L Bailey; S L Cross; L E Samelson; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

2.  A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.

Authors:  D E Smilek; D C Wraith; S Hodgkinson; S Dwivedy; L Steinman; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

3.  T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins.

Authors:  F Letourneur; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 4.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.

Authors:  P J Fairchild; C J Thorpe; P J Travers; D C Wraith
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

5.  Do all programmed cell deaths occur via apoptosis?

Authors:  L M Schwartz; S W Smith; M E Jones; B A Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

6.  Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand.

Authors:  B D Evavold; J Sloan-Lancaster; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

7.  Molecular cloning of the CD3 eta subunit identifies a CD3 zeta-related product in thymus-derived cells.

Authors:  Y J Jin; L K Clayton; F D Howard; S Koyasu; M Sieh; R Steinbrich; G E Tarr; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the zeta chain.

Authors:  J J O'Shea; A M Weissman; I C Kennedy; J R Ortaldo
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

9.  Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events.

Authors:  J Ruppert; J Alexander; K Snoke; M Coggeshall; E Herbert; D McKenzie; H M Grey; A Sette
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  CD3 eta and CD3 zeta are alternatively spliced products of a common genetic locus and are transcriptionally and/or post-transcriptionally regulated during T-cell development.

Authors:  L K Clayton; L D'Adamio; F D Howard; M Sieh; R E Hussey; S Koyasu; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.